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Background: The original method for determining endurance shuttle walk test (ESWT) speed 
involves components that are time consuming for clinicians. We sought to determine: (i) whether 
components described in the original method for determining ESWT speed held true and; (ii) the 
agreement between speeds derived using the original method and that equivalent to 85% of the 
peak speed achieved during the incremental shuttle walk test (ISWT).  
Methods: Patients with chronic obstructive pulmonary disease (COPD) performed two ISWTs 
and one ESWT on separate days, wearing a calibrated portable gas analysis unit. A retrospective 
analysis of these data allowed us to determine whether: (i) the peak rate of oxygen uptake 
( peak2OV
 ) can be accurately estimated from the incremental shuttle walk distance (ISWD) and; 
(ii) ESWTs performed at a speed derived using the original method elicited 85% of peak2OV
 . 
Agreement between walks speeds was determined using Bland-Altman analysis. 
Results: Twenty-two participants (FEV1 48±13% predicted, age 66±8 yr) completed the study. 
The peak2OV
 estimated from the ISWD was less than that measured during the ISWT (mean 




). The ESWT and ISWT 
elicited similar peak2OV
 (mean difference -0.2; 95% CI, -1.5 to 1.2 ml·kg-1·min-1). The mean 
difference (± limits of agreement) between ESWT speeds was 0.15 (± 0.34) km∙h
-1
. 
Conclusions: Components of the original method for determining the ESWT speed did not hold 
true in our sample. ESWT speed can be derived by calculating 85% of the peak speed achieved 




The endurance shuttle walk test (ESWT)
1
 is an assessment of walking endurance that is 
appropriate for assessing the response to interventions in people with chronic obstructive 
pulmonary disease (COPD).
2
 Its popularity as an outcome in clinical studies is increasing, 
largely as a result of its superior responsiveness when compared with other field based walking 
tests, such as the six-minute walk test (6MWT)
3,4
 and the incremental shuttle walk test (ISWT).
1
 
The method for calculating the speed for the ESWT, as described in the original publication,
1
 
involves four components. First, an ISWT is performed and the distance walked (ISWD) is 
recorded. Second the ISWD is entered into a regression equation to estimate an individual’s peak 
rate of oxygen uptake ( peak2OV
 ). Third, a value equivalent to 85% of the estimated peak2OV
 is 
calculated. Fourth, a walk speed corresponding to 85% of the estimated peak2OV
 is derived using a 
published figure that relates walk speed to the rate of oxygen uptake.
1
 This four-component 
process can be time-consuming for clinicians and the reliance on the published figure during the 
final component may lead to imprecision when determining the speed for this test.  
 
We recently compared the cardiorespiratory responses to the 6MWT, ISWT, ESWT with a ramp-
based cycle ergometry test.
5
 A secondary analysis of these data allowed us to determine the 
extent to which the components described in the original method for calculating an appropriate 
speed for the ESWT held true and whether the process for deriving the speed for the ESWT 
could be simplified. The specific aims for this study were to determine: 
1. Whether peak2OV
 can be accurately derived from ISWD. 
2. Whether the rate of oxygen uptake during the ESWT was equivalent to 85% of peak2OV
 .  
5 
 
3. The agreement between ESWT speeds derived using the original four-component process and 
that equivalent to 85% of the peak speed achieved during the ISWT.  
 
METHODS 
Patients with stable COPD were recruited from referrals to pulmonary rehabilitation programs 
and respiratory medicine clinics. Individuals were excluded if they had evidence of a co-morbid 
condition that may have adversely affected their capacity to complete field-based walking tests 
such as severe lower back pain or required a gait aid or supplemental oxygen during exercise. As 
the American Thoracic Society / American College of Chest Physicians statement on 
cardiopulmonary exercise testing
6
 indicates that a decrease in arterial oxygen saturation (SpO2) 
to ≤ 80%, when accompanied by symptoms and signs of severe hypoxaemia is a criterion that 
clinicians should use to terminate an exercise test, we chose to exclude any individual who 
desaturated to this extent during any of the tests. Approval was obtained from the Research 
Ethics Board at our facility and written informed consent was obtained from every participant. 
Age, gender, height and weight were recorded and recent spirometric measures of lung function 
were extracted from the medical notes. Data collection pertaining to the main study
5
 was 
completed over four assessment sessions, each separated by at least one day. During a session, 
participants completed either two 6MWTs, two ISWTs, two ESWTs or one incremental cycle 
ergometry test wearing a calibrated portable gas analysis unit (Cosmed™, K4b
2
, Italy). To meet 
the aims of the current study, data were used for the test that yielded the best ISWD and the first 
of the two ESWTs. The speed for the ESWT was determined according to the method originally 
described.
1
 Standard protocols were used for both tests,
1,7
 and participants were instructed to 







Data analyses were performed using the Statistical Package for Social Sciences (version 19.0, 
SPSS Inc., Chicago, IL, USA) and data are expressed as mean ± standard deviation unless 
otherwise stated.  We estimated peak2OV
 using the following published regression equation:8   
 
Estimated peak2OV
 (ml∙kg-1∙min-1) = 4.19 + (ISWD × 0.025) 
  
and determined if it was different from the peak2OV
 measured directly during the ISWT using a 
paired t-test. Agreement between the estimated and measured peak2OV
 was examined using the 




To determine the extent to which the rate of oxygen uptake measured during the ESWT 
corresponded to 85% of the peak2OV
 achieved during the ISWT, we compared 
the peak2OV
 achieved during the two tests using a paired t-test. Further, the pattern of change in 
the rate of oxygen uptake between the ISWT and ESWT was compared by; (i) grouping data into 
deciles of the total test duration using a two-dimensional data transformation (Sigmaplot
®
, 
version 12.0) and, (ii) fitting a curve to the profile of the mean data for each test. Data collected 




We determined whether the speed equivalent to 85% of the peak speed achieved during the 
ISWT differed from that derived using the original four-component process using a paired t-test 




Sample size calculations 
The results of this study arise from the retrospective analyses of an existing dataset. Therefore, 
sample size calculations were not undertaken to meet the specific aims of this study. 
Nevertheless, our sample size yielded adequate power (α = 0.05, 1-β = 0.8) to detect a difference 
in speeds for the ESWT (i.e. that equivalent to 85% of the peak speed achieved during the ISWT 
and that derived using the original four-component process) of 0.17 ± 0.27 km·h
-1
 (or 2.8 m·min
-
1
). This difference is the smallest difference in pre-recorded speeds available for the ESWT. 
 
RESULTS 
Characteristics of the 22 participants (14 men) are summarised in Table 1 and have been 




The ISWD was 343 ± 104 m (range 180 to 550 m). The speed for the ESWT was 4.29 ± 0.64 
km∙h
-1
 (range 3.27 to 5.54 km∙h
-1
) and the time to symptom limitation was 378 ± 298 s (range 
115 to 1156 s).  
 
Results addressing aim 1 
The peak2OV
 estimated using the ISWD was 12.8 ± 2.6 ml∙kg-1∙min-1 and the peak2OV
 measured 















). The published 
regression equation underestimated peak2OV
 in 19 (86%) participants. Significant 
heteroscedasticity was observed as the difference between estimated and measured 
peak2OV
 increased as peak2OV
  increased (slope = -0.683; p = 0.001) (Figure 1). 
 
Results addressing aim 2 
The peak2OV
 measured during the ESWT was 17.4 ± 4.4 ml·kg-1·min-1. The difference between 
the peak2OV
 achieved during the ESWT and ISWT was not significant (mean difference -0.2; 95% 




). The profiles of peak2OV
 measured during the ISWT and ESWT are 
shown in Figure 2. The oxygen uptake at the beginning of the ISWT was less than that observed 
for the ESWT because the ISWT was initiated from a stationary standing position, whereas, the 
ESWT commenced after a 90 second warm-up walk and data collected during this warm-up were 
excluded from the analyses. The increase in the rate of oxygen uptake with increasing time 
during the ISWT could be described by the following linear function: 
 
2OV
 = 5.34 + (2 × t); t = time (min) 
 
Consistent with previous work that has explored the cardiorespiratory responses to a constant 
power test,
10
 the increase in the rate of oxygen uptake with increasing time during the ESWT 
could be described by the following three-parameter single exponential function: 
 
2OV




During the ESWT, every participant exceeded 85% of the peak2OV
 estimated from the ISWD. Of 
note, in Figure 2, the shaded area, which indicates the 95% CI for values equivalent to 85% 
of peak2OV
 estimated using the ISWD, was achieved within the first 0.5 ± 0.5 min of the ESWT. 
 
Results addressing aim 3  
The speed equivalent to 85% of the peak speed achieved during the ISWT was 4.44 ± 0.67 km∙h
-
1
 (range 3.09 to 5.69 km∙h
-1
).The mean difference between this speed and that derived using the 
original method was 0.15 km∙h
-1
 (95% CI, 0.07 to 0.22 km∙h
-1
). The two methods resulted in 
identical speeds for 8 (36%) participants and a difference of one speed (of those available for the 
ESWT) in 14 (64%) participants (Figure 3). 
 
DISCUSSION  
This study explored whether the peak rate of oxygen uptake ( peak2OV
 ) can be accurately 
estimated from the ISWD and whether ESWTs performed at a speed derived using the original 
four-component process elicited 85% of peak2OV
 . In addition, it determined whether a simple 
process for calculating the speed for the ESWT produced similar speeds as the original four-
component process. An important finding of this study was that the regression equation used to 
derive peak2OV
 from the ISWD resulted in a significant underestimation of the directly measured 
peak2OV
 . Further, our data indicate that the peak2OV
 achieved during the ESWT approached the 
peak2OV
 directly measured during the ISWT thereby exceeding a value equivalent to 85% of 
the peak2OV
 estimated from the ISWD. Nevertheless, on average, the speed for the ESWT derived 
10 
 
using the original four-component process resulted in a desirable duration for time to symptom 
limitation of between 4 and 7 min.
11
 Our data suggest that using 85% of the peak walk speed 
achieved during the ISWT produced similar speeds for the ESWT when compared with that 
derived using the original four-component process. These findings indicate that components of 
the original method described to calculate the speed for the ESWT may not hold true in patients 
with COPD and are unnecessary when calculating the speed for the ESWT. We propose that the 
speed for this test can be simply determined by calculating 85% of the peak speed achieved 
during the ISWT. 
 
When determining the speed for the ESWT, VO2peak is estimated in order to relate the intensity of 
the test to an individual’s aerobic capacity
1
 and to achieve a baseline endurance time within the 
responsive range.
11
 The equation published to estimate peak2OV
 included ISWD as the sole 
independent variable and peak2OV
 measured during an incremental symptom-limited treadmill test 
as the dependent variable.
8
 Our data demonstrated that this equation produced values that were 
significantly less than those directly measured during the test. The reasons for this do not appear 
to be related to differences in the samples between the studies. That is, compared with our 
sample, the participants in the original study had similar disease severity (forced expiratory 
volume in one second; 1.1 ± 0.4 L vs. 1.4 ± 0.5 L) and functional impairment (ISWD; 343 ± 104 
m vs. 375 ± 137 m).
8
 Further, both studies used the same ISWT protocol.
8
 However, in contrast 
with our study which measured peak2OV
 using a portable gas analysis system during the ISWT, 
the original paper measured the peak2OV
 during a laboratory-based treadmill test.8 Compared to 
ground walking with frequent turns back and forth around a 10 m course, treadmill walking 
11 
 
requires less energy and is more efficient.
1
 When walking at similar speeds, these differences 
produced a consistent tendency to walk for longer on a treadmill compared with ground 
walking.
1
 The reduced efficiency associated with ground walking around a 10 m course is likely 
to have increased the rate of oxygen uptake for any given ISWD when compared with 
measurements made during treadmill walking. The weight of the portable gas analysis unit worn 
by the participants in our study would also have contributed a small amount to the higher rate of 
oxygen uptake. We speculate these to be the reasons why the published regression equation 
underestimated the measured peak2OV
 achieved during the ISWT in our sample.  
 
The original paper describing the ESWT investigated the appropriateness of treadmill walk 
speeds corresponding to 75%, 85% and 95% of the peak2OV
 measured during a symptom-limited 
incremental treadmill test.
1
 They concluded that a speed corresponding to 85% of peak2OV
 was 
most appropriate as; (i) unlike the test performed at 95% of peak2OV
 , it did not provoke a similar 
response as the ISWT, (ii) compared with the test performed at 75% of peak2OV
 , a smaller 
proportion of tests were terminated by the investigator as the patients reached the upper limit of 
20 min and, (iii) the exercise times were of an appropriate duration (i.e. 10.2 ± 2.5 min). In the 
original study, the peak2OV
 elicited whilst walking on a treadmill at this speed corresponded to 87 
± 13% of peak2OV
 .1 In contrast with this study which evaluated responses during treadmill 
walking,
1
 we compared the peak2OV
 achieved during the ESWT with that achieved during an 
ISWT, both of which necessitated ground walking around a 10 m course. Our data demonstrated 
that the rate of oxygen uptake achieved during the ESWT, performed at a speed derived using 
the original four-component process, was similar to the peak2OV
  measured during the ISWT. This 
12 
 
is consistent with previous data showing that patients with COPD achieved a 
similar peak2OV
 cycling at 85% of peak power when compared with that measured during an 
incremental cycle ergometry test.
12
 Figure 2 demonstrates that, on average, patients with COPD 
have achieved a rate of oxygen uptake equivalent to 85% of the peak2OV
 , estimated using the 
published regression equation, within the first 0.5 min of the ESWT. These data do not suggest 
that the speed chosen for the ESWT was inappropriate. In fact, the time to symptom limitation 
measured in our study (378 ± 298 s) is likely to be highly responsive to change,
11,13
 and suggests 
that the speed was close to 120% of the maximum sustainable walking speed.
13
 Rather, these 
data simply highlight that an ESWT performed at a speed derived using the original four-
component process will elicit a peak2OV
 that exceeds 85% of the peak2OV
 estimated from the 
ISWD.  
 
Our data demonstrate similarity between the speeds derived for the ESWT using the original 
four-component process and that calculated to be 85% of the peak speed achieved during the 
ISWT. Of note, these two methods differed, on average, by 0.15 km∙h
-1
 (i.e. 2.5 m∙min
-1
). An 
increase in walking speed of this magnitude has the potential to reduce the time to symptom 
limitation by approximately one minute.
13
 However, given that performance improves with 
familiarisation by an average of 50 to 60 sec,
1,5
 any reduction in time to symptom limitation 
reduction is likely to be offset, at least in part, by repeating the test. This suggests that the speed 
for the ESWT can be derived by simply calculating 85% of the peak speed achieved during the 





The main limitation of this study was that we did not measure the time to symptom limitation 
achieved during the ESWT performed at a speed equivalent to 85% of the peak speed achieved 
during the ISWT and further research is needed in this area. Notwithstanding this, we estimated 
the difference in time to symptom limitation during the ESWT performed at this slightly faster 
speed using our previously published data demonstrating the power-endurance relationship 
during walking tasks in COPD.
13
 As patients who use gait aids and supplemental oxygen were 
excluded, it is possible that our results do not extend to these sub-groups. Further, as the study 
sample was characterised by moderate to severe COPD, it is unclear if our results extend to 
individuals with mild or very severe disease. 
 
Conclusions 
In a sample of participants with stable COPD, our data suggest that the regression equation used 
to derive peak2OV
 from the ISWD resulted in a significant underestimation of the directly 
measured value and that the peak2OV
 achieved during the ESWT exceeded a value equivalent to 
85% of the peak2OV
 estimated from the ISWD. Further, speeds equivalent to 85% of the peak walk 
speed achieved during the ISWT were similar to that derived using the original four-component 
process. Taken together, these results suggest that components described in the original method 
for determining the speed for the ESWT did not hold true and are unnecessary. We propose that 
speeds for the ESWT can be simply derived by calculating 85% of the peak speed achieved 
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Figure 1: Bland-Altman plot demonstrating agreement between peak2OV
  
estimated using the published regression equation and peak2OV
  directly 





. Limits of agreement were not calculated as the 
difference between the measures was systematic. The dashed line indicates 
no difference between the measures. Note that 19 (86%) data points are 
located below the dashed line indicating that the regression equation 
underestimated peak2OV



















Figure 2: Change in 2OV
 during the incremental shuttle walk test (open 
circles) and endurance shuttle walk test (closed circles) plotted using the 
functions reported in the text. Data are mean ± SEM. Dashed black line 
represents the mean value equivalent to 85% of the peak2OV
 estimated from the 
ISWD. The grey box represents the 95% confidence interval around this mean 
value. Of note, the peak2OV
 achieved during the ESWT exceeded 85% of 
the peak2OV




mean speed calculated for ESWT using the 























































Figure 3: Bland-Altman plot demonstrating agreement between the speed 
determined for the endurance shuttle walk test (ESWT) using the original 
method and that equivalent to 85% of the peak speed achieved during the 
incremental shuttle walk test (new method). Solid black line indicates bias 
(mean difference) equal to 0.15 km∙h
-1
. Dashed lines represent limits of 
agreement equal to 0.34 km∙h
-1
. The size of each point (and the number 
written inside) represents the number of data points with that x,y coordinate.  

















Table 1: Characteristics of the participants 
Variable Mean ± SD 
Age (yr) 66 ± 8 
BMI (kg/m
2
) 27.2 ± 5.5 
Height (m) 1.63 ± 0.10 
Weight (kg) 71.9 ± 13.6 
FEV1 (L) 1.13 ± 0.35 
FEV1 % predicted 48.5 ± 13.0 
BMI: body mass index; FEV1: forced expiratory volume in one second 
